Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Enterprise Value (2024 - 2025)

Historic Enterprise Value for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to -$549.7 million.

  • Kura Oncology's Enterprise Value fell 2072.67% to -$549.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$549.7 million, marking a year-over-year decrease of 2072.67%. This contributed to the annual value of -$727.4 million for FY2024, which is N/A changed from last year.
  • Per Kura Oncology's latest filing, its Enterprise Value stood at -$549.7 million for Q3 2025, which was down 2072.67% from -$630.7 million recorded in Q2 2025.
  • Kura Oncology's 5-year Enterprise Value high stood at -$455.3 million for Q3 2024, and its period low was -$727.4 million during Q4 2024.